Participants 137 161 3
metastatic breast cancer
Participants 284 322 5
patients with metastatic breast cancer
Participants 868 995 6
LTS Despite over-accrual of 475 patients, the trial matured with only 324 of 385 planned TtP events due to patient discontinuat
